AP
XENT

AlpInvest Partners’s Intersect ENT, Inc XENT Stock Holding History

AlpInvest Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,250
Closed -$213K – 26
2015
Q1 		$213K Buy
+8,250
New +$189K 0.4% 23

Other funds holding XENT

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

AlpInvest Partners's XENT Position: Q2 2015 in Review

AlpInvest Partners sold out of Intersect ENT, Inc (XENT) in Q2 2015, closing a stake of 8,250 shares — an estimated $213K sold.

AlpInvest Partners first reported a position in XENT in Q1 2015 and held it in 1 quarter. The position peaked at $213K in Q1 2015. 128 funds tracked by Wall St. Rank hold XENT as of Q2 2015.

  • AlpInvest Partners reported no remaining Intersect ENT, Inc position as of Q2 2015 after selling out during the quarter.
  • AlpInvest Partners sold 8,250 Intersect ENT, Inc shares in Q2 2015, an estimated $213K.
  • AlpInvest Partners first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 1 quarter.
  • AlpInvest Partners's Intersect ENT, Inc position peaked at $213K in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2015.

Based on AlpInvest Partners's 13F filing for Q2 2015, filed 14 Aug 2015.